Cell MedX (OTCMKTS:CMXC) Shares Down 7.7%

Shares of Cell MedX Corp. (OTCMKTS:CMXC) were down 7.7% on Tuesday . The stock traded as low as $0.18 and last traded at $0.18. Approximately 39,147 shares changed hands during trading, a decline of 12% from the average daily volume of 44,631 shares. The stock had previously closed at $0.20.

The firm has a 50 day moving average price of $0.18 and a two-hundred day moving average price of $0.23.

About Cell MedX (OTCMKTS:CMXC)

Cell MedX Corp. is a biotech company, which engages in the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness. Its products include microcurrent therapy and eBalance systems. The company was founded on March 19, 2010 and is headquartered in Carson City, NV.

Read More: What are municipal bonds?

Receive News & Ratings for Cell MedX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cell MedX and related companies with MarketBeat.com's FREE daily email newsletter.